
CASE DISCUSSION
Management of Stroke in ICU
Views
29,352
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Rapid transfer of stroke patients to the ICU allows for immediate assessment and intervention.Continuous monitoring of vital signs, neurological status, and oxygen saturation is essential to detect changes promptly. Administration of clot-dissolving agents like tissue plasminogen activator (tPA)...
Case Summary
- Stroke, or cerebrovascular accident, can be ischemic (due to a blockage) or hemorrhagic (due to bleeding). Stroke is essentially a brain attack, with the first 180 minutes being critical for intervention. Early diagnosis and treatment are crucial, as every second counts due to neuron loss.
Speaker Profile

Dr. Pooja Wadwa
Alumni- Royal Melbourne HospitalAdditional Director, Critical Care Medicine, ECMO Specialist, FMRI, Gurgaon
Clinical Director, Critical Care Medicine & ECMO Specialist, Marengo Asia Hospitals, Gurgaon (formerly Additional Director, FMRI)
Dr. Pooja Wadwa is a highly experienced critical care specialist and ECMO expert with over 12 years in the field. She completed her MBBS (2002) from Indira Gandhi Medical College, Nagpur, and MD (Internal Medicine, 2006) from Dayanand Medical College & Hospital, Ludhiana. She also underwent an ICU Observership at Royal Melbourne Hospital, Australia, and completed her IDCCM (Indian Diploma in Critical Care Medicine) from Indraprastha Apollo Hospital, New Delhi. She was previously the Additional Director of Critical Care Medicine and an ECMO Specialist at Fortis Memorial Research Institute (FMRI), Gurgaon, where she was instrumental in developing ECMO protocols and raising critical care standards. She has recently joined Marengo Asia Hospitals, Gurugram, as Clinical Director of Critical Care Medicine, focusing on digital ICU technologies, ECMO expansion, and advanced critical care delivery.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.